IMCD acquires US specialty pharmaceutical ingredient distributor Mutchler Inc. and Mutchler of Puerto Rico Inc.

July 1 2016, David R Brown

IMCD N.V., a leading distributor of specialty chemicals, pharmaceutical and food ingredients, has announced that it has acquired 100% of Mutchler Inc. and Mutchler of Puerto Rico Inc.. With a focus on the pharmaceutical market, Mutchler complements IMCD's existing US operations. Mutchler is a leading specialty pharmaceutical ingredient distributor in the US and Puerto Rico with offices in Harrington Park, New Jersey and Puerto Rico. Mutchler is active in all US states and Puerto Rico and represents leading global pharmaceutical ingredient suppliers. In 2015, Mutchler generated revenue of USD 28 million and has approximately 30 employees.

This is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD

Marcus Jordan
President of IMCD Holdings US Inc.

Mutchler appears to be an excellent fit with IMCD asset light business model and supports IMCD's stated stratgy of becoming the leading global specialty chemicals distributor providing expertise and knowledge based formulation solutions to its customers.

Marcus Jordan, President of IMCD Holdings US Inc., commented: “Following the acquisition of MF Cachat (now IMCD US) in June 2015, this is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD. Mutchler has a reputation as a leading pharmaceutical ingredient supplier and we very much look forward to working together to further develop our offering to both suppliers and customers.”

Dwight Mutchler, President of Mutchler, adds: “We are delighted to become part of IMCD as the alliance immediately propels Mutchler into the future with a larger and more specialized team and added technical know-how.”

About IMCD N.V.
IMCD is a market-leader in the sales, marketing and distribution of specialty chemicals and food ingredients in Europe, Africa, Asia-Pacific and Americas. Listed at Euronext, Amsterdam (IMCD.AS), IMCD realised revenues of €1,530 million in 2015. In over 40 countries on 6 continents its dedicated team of more than 1,700 technical and commercial experts work in close partnership to tailor best in class solutions for around 32,000 customers and a diverse range of world class suppliers.

Source(s): IMCD Press Release

Further Information

Visit: http://www.imcdgroup.com

Attention Chemical Distributors!
Please send your press releases to: support@chemagility.com